Fig. 5
From: CRISPR-Cas9 screening identifies a gene signature predictive of prognosis in glioblastoma
Association between the proliferation-related essential genes signature and clinicopathological features in glioblastoma patients. (a) Heatmap displaying the relationship between the risk score, clinicopathological features (age, gender, IDH status, MGMT promoter status, and survival status), and the expression of the five signature genes. (b) Boxplots illustrating the distribution of risk scores across clinicopathological subgroups. (c–j) Kaplan-Meier survival curves for glioblastoma patients stratified by age, gender, IDH status, and MGMT promoter status.
